New nasal COVID vaccine could replace shots
⭐️ VACCINE ⭐️
Ongoing
This Phase 2a trial tests a new nasal COVID-19 vaccine (NDV-HXP-S-KP.2) against an approved mRNA shot in 200 adults who have already been vaccinated. The goal is to see if the nasal vaccine is safe and tolerable. Participants are either 65 or older, or 18-64 with a condition that…
Phase: PHASE2 • Sponsor: CastleVax Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 24, 2026 00:00 UTC